UTILIZING METFORMIN TO ENHANCE THE EFFICACY OF ANDROGEN DEPRIVATION THERAPY IN THE TREATMENT OF PROSTATE CANCER.

被引：0
|
作者：
Colquhoun, Alexandra
Venier, Natalie
Fleshner, Neil
Pollak, Michael
Klotz, Laurence
Venkateswaran, Vasundara
机构：
来源：
JOURNAL OF UROLOGY | 2010年 / 183卷 / 04期
关键词：
D O I：
10.1016/j.juro.2010.02.148
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
99
引用
收藏
页码：E41 / E41
页数：1
相关论文
共 50 条
  • [1] Utilizing metformin to enhance the efficacy of androgen deprivation therapy in the treatment of prostate cancer
    Colquhoun, Alexandra J.
    Venier, Natalie A.
    Fleshner, Neil E.
    Pollak, Michael
    Klotz, Laurence H.
    Venkateswaran, Vasundara
    CANCER RESEARCH, 2010, 70
  • [2] UTILIZING METFORMIN TO ENHANCE THE EFFICACY OF ANDROGEN DEPRIVATION THERAPY IN THE TREATMENT OF PROSTATE CANCER
    Colquhoun, Alexandra
    Venier, Natalie
    Vandersluis, Avi
    Fleshner, Neil
    Pollak, Michael
    Klotz, Laurence
    Venkateswaran, Vasundara
    JOURNAL OF UROLOGY, 2011, 185 (04): : E293 - E293
  • [3] Utilizing metformin to enhance the efficacy of androgen-deprivation therapy in the treatment of prostate cancer
    Klotz, L.
    Venier, N.
    Vandersluis, A.
    Besla, R.
    Fleshner, N.
    Pollak, M. N.
    Venkateswaran, V.
    Colquhoun, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [4] UTILISING METFORMIN TO ENHANCE THE EFFICACY OF ANDROGEN DEPRIVATION THERAPY IN THE TREATMENT OF PROSTATE CANCER
    Colquhoun, A. J.
    Venier, N. A.
    Vandersluis, A. D.
    Besla, R.
    Fleshner, N. E.
    Pollak, M.
    Klotz, L. H.
    Venkateswaran, V.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 293 - 293
  • [5] UTILISING METFORMIN TO ENHANCE THE EFFICACY OF ANDROGEN DEPRIVATION THERAPY IN THE TREATMENT OF PROSTATE CANCER
    Colquhoun, A. J.
    Venier, N. A.
    Fleshner, N. E.
    Pollak, M.
    Klotz, L. H.
    Venkateswaran, V.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 219 - 219
  • [6] METFORMIN ASSOCIATED WITH ANDROGEN DEPRIVATION THERAPY IN PROSTATE CANCER PATIENTS
    Yakout, Ibrahim Abdelnasar
    Gallab, Mohamed Mustafa
    Mohamed, Daie Abdelrahman
    Hamdar, Hiba
    Amayem, Sara
    Mohamed, Adham
    Abdelshafi, Abdelrahman
    Abd-ElGawad, Mohamed
    ATHEROSCLEROSIS, 2024, 399
  • [7] Androgen deprivation therapy in prostate cancer. Indication and systemic consequences
    Rohayem, J.
    Kliesch, S.
    UROLOGE, 2012, 51 (04): : 557 - 564
  • [8] Reimbursement Policy and Androgen-Deprivation Therapy for Prostate Cancer.
    Shahinian, Vahakn B.
    Kuo, Yong-Fang
    Gilbert, Scott M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (19): : 1822 - 1832
  • [9] Androgen deprivation therapy in advanced prostate cancer. Multicenter study
    Jose Valencia-Guadalajara, Victor
    Martinez-Cayuelas, Laura
    Sarrio-Sanz, Pau
    Sanchez-Caballero, Laura
    Polo-Hernandez, Rebeca
    Silvia Chillon-Sempere, Francisca
    Antonio Galan-Llopis, Juan
    Garces-Valverde, Marina
    Antonio Tenza-Tenza, Jose
    Costa-Martinez, Asuncion
    Garcia Serrado-Paumard, Diego
    Escudero-Fontana, Eva
    Tello-Royloa, Carlos
    Patricia Verdu-Verdu, Lidia
    Fernando Bravo-Lopez, Diego
    Perez Seoane-Ballester, Helena
    Jose Pacheco-Bru, Juan
    Angel Ortiz-Gorraiz, Manuel
    ARCHIVOS ESPANOLES DE UROLOGIA, 2020, 73 (06): : 499 - 508
  • [10] Outcomes of androgen deprivation as sole therapy for localized prostate cancer.
    Janoff, D
    Mongoue-Tchokote, S
    Peterson, C
    Parra, RO
    Peters, L
    Park, Y
    Beer, TM
    Mori, M
    Garzotto, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 413S - 413S
12345